- Location
anti inflammatory drug
"-
The U.S. Food and Drug Administration (FDA) Has Approved The New Drug Application
Jan 17, 2014Mallinckrodt (NYSE: MNK) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for PENNSAID® (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal ...
-
U.S. Food and Drug Administration (FDA) Has Accepted for Review The SNDA
Jan 16, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
-
FDA Has Accepted for Review The Supplemental New Drug Application
Jan 15, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
-
Hangover Headaches Are a Problem Over Holidays,But There Are Ways to Prevent Them
Jan 3, 2014Hangover headaches are a common problem over the holidays, but there are ways to prevent them, an expert says. The best way to avoid a hangover headache is to stick to non-alcoholic drinks such as sodas, spritzers and punches, said Dr. ...
-
Drug Preserved The Quality of Life in Patients with Familial Transthyretin Amyloidosis
Dec 27, 2013A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological ...
Tags: diflunisal, anti-inflammatory drug, transthyretin amyloidosis, arthritis
-
Iroko Has Entered Into a $75m Debt Facility Agreement with an Affiliate of OrbiMed
Nov 22, 2013US-based Iroko Pharmaceuticals has entered into a $75m debt facility agreement with an affiliate of OrbiMed Advisors (OrbiMed) to support general business operations and the launch of Zorvolex (diclofenac). Zorvolex is the first and only ...
-
They Developed a Squishy Gel Compressed,Like at a Painful Knee Joint,Releases Medicine
Nov 12, 2013U.S. scientists say they developed a squishy gel that when compressed -- like at a painful knee joint -- releases anti-inflammatory medicine. Xinqiao Jia, Chandran R. Sabanayagam and colleagues at the University of Delaware said in the ...
Tags: hydro gel, compresse, anti-inflammatory, Painful Joint, move
-
Iroko Pharmaceuticals Has Received The FDA Approval to Market ZORVOLEX Capsules
Oct 23, 2013US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...
-
Imprimis Pharmaceuticals Has Received Approval From The Institutional Review Board
Jul 26, 2013Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...
-
AbbVie's Humira Was Rejected by The US FDA Advisors for Use in The Treatment
Jul 25, 2013AbbVie's Humira (adalimumab), a rheumatoid arthritis drug, has been rejected by the US FDA advisors for use in the treatment of a spinal inflammatory disease, non-radiographic axial spondyloarthritis. The FDA's Arthritis Advisory ...
-
Iroko Has Announced The FDA Acceptance for New Drug Application
Jul 18, 2013Specialty pharmaceutical company Iroko Pharmaceuticals has announced the FDA acceptance for New Drug Application (NDA) filing of lower dose submicron Indomethacin, a non-steroidal anti-inflammatory drug. The proposed indication of the ...
Tags: FDA Acceptance, NDA Filing
-
Norwegian Cardiovascular Biopharma Serodus Signed a Merger Agreement with Signed a Merger
Jul 12, 2013Norwegian cardiovascular biopharma Serodus has signed a merger agreement with Danish peptide specialist Phlogo to expand cardiovascular drug candidate portfolio. Subject to approval by an EGM, the merger is expected to accelerate Serodus' ...
-
EFSA, EMA to Evaluate The Risk for Consumers Arising From The Presence of Residues
Mar 11, 2013The European Commission has asked the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) to evaluate the risk for consumers arising from the presence of residues of anti-inflammatory drug phenylbutazone in ...
-
FDA Has Accepted to Review Iroko Pharmaceuticals New Drug Application
Mar 8, 2013The US Food and Drug Administration (FDA) has accepted to review Iroko Pharmaceuticals New Drug Application (NDA) for lower dose submicron diclofenac, a non-steroidal anti-inflammatory drug (NSAID), with a proposed indication of treatment ...
Tags: FDA, Pharmaceuticals, Medicine
-
Imprimis Pharmaceuticals Has Announced The Completion of Clinical Trials of Impracor
Feb 21, 2013Imprimis Pharmaceuticals has announced the completion of clinical trials of Impracor, a topical analgesic cream, which delivers a therapeutic dose of the pain-relieving, anti-inflammatory drug ketoprofen. The study, which was conducted by ...
Related Products
-
500 OEM/ODM Colistin Sulfate and Amoxicillin Trihydrate Soluble Powder for Cattle Chicken Sheep Pig Duck
-
Animal High-Efficiency Antipyretic and Anti-Inflammatory Drugs 30%50% Analgin Injection Suitable for Livestock and Pets
-
Animal Anti-Inflammatory and Antipyretic Drugs Analgin Injection 25%30% Antibiotics Suitable for Livestock and Pets Low Price
-
Veterinary Drug Manufacturers Direct Sales Gentomycin Sulfate Injection 4% 5% 10% for Cattle, Horses, Sheep, Dogs and Cats Anti-Allergic and Anti-Inflammatory
-
Analgin Injection Animal Antibacterial Anti-Inflammatory Antipyretic Anti-Inflammatory GMP Veterinary Drug Factory
-
Wholesale Drugs Raw Material 98% Myricetin Bayberry Bark Extract for Anti-Inflammatory and Anti-Infection
